Single Ascending Dose Tolerability Study of DG3173
Clinical trial NCT02217488 · COMPLETED
Trial details
- NCT number
- NCT02217488
- Sponsor
- Aspireo Pharmaceuticals Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2008-09-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.